Viewing Study NCT01204866


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2026-01-24 @ 9:50 PM
Study NCT ID: NCT01204866
Status: COMPLETED
Last Update Posted: 2010-09-24
First Post: 2010-09-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use
Sponsor: PharmAthene, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module